Showing 1,421 - 1,440 results of 116,965 for search '(( a non decrease ) OR ( 5 ((((wt decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.75s Refine Results
  1. 1421

    Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

    Published 2013
    “…The relative expression (2<sup>-ΔΔCt</sup> mean ± SEM) of hepatic CYP3A4 mRNA was significantly higher in cirrhotic livers (21.76 ± 2.65 vs. 5.91 ± 1.29, P=2.04E-07) but their levels did not significantly correlate with hepatic CYP3A activity (r=-0.43, P=0.08).…”
  2. 1422
  3. 1423
  4. 1424
  5. 1425
  6. 1426
  7. 1427
  8. 1428

    Effect of Acidic Polymers on the Morphology of Laser-Induced Nucleation of Cesium Chloride by Yao Liu (173014)

    Published 2021
    “…Here, we apply the technique of non-photochemical laser-induced nucleation to irradiate a supersaturated solution (<i>S</i> = 1.15) of cesium chloride (CsCl). …”
  9. 1429

    Effect of Acidic Polymers on the Morphology of Laser-Induced Nucleation of Cesium Chloride by Yao Liu (173014)

    Published 2021
    “…Here, we apply the technique of non-photochemical laser-induced nucleation to irradiate a supersaturated solution (<i>S</i> = 1.15) of cesium chloride (CsCl). …”
  10. 1430
  11. 1431
  12. 1432
  13. 1433

    Deterioration of the anammox process at decreasing temperatures and long SRTs by Maaike Hoekstra (3915545)

    Published 2017
    “…The long SRT leads to an increase of non-active and non-anammox cells in the reactor, thereby decreasing the biomass-specific activity.…”
  14. 1434
  15. 1435

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

    Published 2025
    “…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
  16. 1436
  17. 1437

    ANG II treatment leads to decreased contractile function. by Renita E. Horton (847891)

    Published 2016
    “…(E) Representative stress traces generated from x-projections of films (F) ANG II treatment leads to a decrease in contractile stress generation. Control n = 85 tissues, 5 nM n = 15 tissues, 100 nM n = 69 tissues, 3 harvests. …”
  18. 1438
  19. 1439

    EGCG decreases RSK2-mediated cell viability. by Hanyong Chen (320863)

    Published 2015
    “…Differences were evaluated using the Student’s t-test and the asterisk (*) indicates a significant decrease in viability in RSK2<sup>+/+</sup> MEFs compared to RSK2<sup>-/-</sup> MEFs (<i>p</i> < 0.05).…”
  20. 1440

    Knockdown of VGLUT1 results in a concomitant decrease in synaptic expression of synapsin and synaptophysin. by Corbett T. Berry (296520)

    Published 2013
    “…(<b>E</b>) Synaptophysin was not decreased in KD neurons co-expressing VGLUT1 (<i>V1</i>, VGLUT1 expressing neurons; p = 0.940; n = 244 and 96 puncta from 13 and 9 axons for SCR and V1, respectively, from a representative experiment. …”